Patient Perspective of 520 Cancer Patient Groups on the Corporate Reputation of Pharma in 2023/2024: Roche Ranked 1st, AstraZeneca Ranked 2nd, and Pfizer Ranked 3rd [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
Views of 520 Cancer Patient Groups" report has been added to ResearchAndMarkets.com's offering. The Corporate Reputation of Pharma - from the Perspective of Cancer Patient Groups, 2023 is the 11th cancer edition in the annual ' Corporate Reputation' series. The review contains the results of a November 2023 to late-February 2024 survey, answered by 570 cancer patient groups. 2023's 570 respondent cancer patient groups were headquartered in 75 countries - the largest representation (113 respondent patient groups) being from the USA. The 570 stated that, collectively, they had actively supported and served almost 10 million patients living with cancer during 2023. Continue reading, for details about: The headline industry-wide cancer results of the 2023 survey. The performance at corporate reputation of the 28 individual pharma companies included in the 2023 cancer analysis. Summary of Results Industry Wide: Several factors may have influenced the opinions of 2023's resp
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer [Yahoo! Finance]Yahoo! Finance
- AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer [Yahoo! Finance]Yahoo! Finance
- Impact and implications of the $35 monthly price cap on asthma inhalers [Yahoo! Finance]Yahoo! Finance
- China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients [Yahoo! Finance]Yahoo! Finance
- Corporate Reputation of Pharma in Canada, 2023/2024: The Views of 100 Canadian Patient Groups - Fair Pricing Policies, Transparency of Pricing, and Engaging Patients in R&D Among the Lowest-Scoring Indicators [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 6/26/24 - Form 11-K
- 6/25/24 - Form 6-K
- 6/25/24 - Form 6-K
- AZN's page on the SEC website